test

Craig Skaling

@Tcg Crossover Management, Llc

Latest period2024 - Q3ReportedManaged Assets$1.18BTotal holdings36
Assets growth rate23.02%Assets growth rate (2-Q avg)-0.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Tcg Crossover Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Tcg Crossover Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.18B in assets, with a quarterly growth rate of 23.02% and a 2-quarter average growth rate of -0.56%. The portfolio is managed by Craig Skaling, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
GPCRStructure Therapeutics Inc
Recent Activity
Increased 53.05%
3.96%
$46.655M
1.063M shares@ $43.89 avg price
OCULOcular Therapeutix, Inc.
Recent Activity
3.93%
$46.277M
5.319M shares@ $8.71 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
3.92%
$46.224M
2.891M shares@ $16.0 avg price
TRMLTourmaline Bio Inc
Recent Activity
3.22%
$37.989M
1.478M shares@ $25.71 avg price
THRDThird Harmonic Bio Inc
Recent Activity
New Position
2.78%
$32.723M
2.415M shares@ $13.55 avg price
ATXSAstria Therapeutics, Inc.
Recent Activity
2.58%
$30.408M
2.762M shares@ $11.02 avg price
MLYSMineralys Therapeutics, Inc.
Recent Activity
Decreased -22.44%
2.54%
$29.915M
2.47M shares@ $12.11 avg price
KURAKura Oncology Inc
Recent Activity
2.36%
$27.818M
1.424M shares@ $19.55 avg price
SLNOSoleno Therapeutivs, Inc.
Recent Activity
New Position
2.36%
$27.769M
550,000 shares@ $50.49 avg price
CMPSCompass Pathways Plc
Recent Activity
2.06%
$24.305M
3.858M shares@ $6.3 avg price